Ulrike Fuhrmann

Bayer (Germany) — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

15h-index1.4kcitations23works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(13), Endometriosis Research and Treatment(6), Glycosylation and Glycoproteins Research(4), Hormonal Regulation and Hypertension(4), Monoclonal and Polyclonal Antibodies Research(3)

Publications23 total

New Approaches to Drug Discovery
Handbook of experimental pharmacology·2016· 41 cited
The last decade has seen many exciting new medicines being introduced to the market. Introduction.
PubMed·2016
Tissue Remodeling and Nonendometrium-Like Menstrual Cycling Are Hallmarks of Peritoneal Endometriosis Lesions
Reproductive Sciences·2012· 22 cited
Mast cells in endometriosis: guilty or innocent bystanders?
Expert Opinion on Therapeutic Targets·2012· 49 cited
Effect of mutations of the human serpin protein corticosteroid-binding globulin on cortisol-binding, thermal and protease sensitivity
The Journal of Steroid Biochemistry and Molecular Biology·2010· 6 cited
In vitro characterization of ZK 230211—A type III progesterone receptor antagonist with enhanced antiproliferative properties
The Journal of Steroid Biochemistry and Molecular Biology·2010· 27 cited
Global gene expression profiling of progesterone receptor modulators in T47D cells provides a new classification system
The Journal of Steroid Biochemistry and Molecular Biology·2008· 33 cited
Effects of progesterone receptor antagonists on breast cancer
2002· 3 cited
ChemInform Abstract: Synthesis and Biological Activity of a Novel, Highly Potent Progesterone Receptor Antagonist.
ChemInform·2001
Synthesis and Biological Activity of a Novel, Highly Potent Progesterone Receptor Antagonist
Journal of Medicinal Chemistry·2000· 97 citedOpen Access
Misexpression of Wild-Type and Truncated Isoforms of the High-Mobility Group I Proteins HMGI-C and HMGI(Y) in Uterine Leiomyomas
American Journal Of Pathology·1999· 57 citedOpen Access
Recent developments in molecular action of antihormones
Journal of Molecular Medicine·1998· 25 cited
Steroid hormone action 1998: novel challenges for drug design
Journal of Molecular Medicine·1998· 2 cited
Comparative Messenger Ribonucleic Acid Analysis of Immediate Early Genes and Sex Steroid Receptors in Human Leiomyoma and Healthy Myometrium
The Journal of Clinical Endocrinology & Metabolism·1997· 52 cited
The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential
Contraception·1996· 195 cited
Drospirenone: a Novel Progestogen with Antimineralocorticoid and Antiandrogenic Activity
Annals of the New York Academy of Sciences·1995· 183 cited
Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays
Contraception·1995· 52 cited
DNA-binding of androgen receptor overexpressed in mammalian cells
The Journal of Steroid Biochemistry and Molecular Biology·1994· 6 cited
Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: Inhibition of cat expression by anti-androgens
The Journal of Steroid Biochemistry and Molecular Biology·1992· 53 cited
Amino Acid Sequences in the Alpha 1 Domain and Not Glycosylation are Important in HLA-A2/β2-Microglobulin Association and Cell Surface Expression
Molecular and Cellular Biology·1987· 14 cited
page 1 of 2Next →

Frequent Co-authors

Karl‐Heinrich Fritzemeier(4), Jens Hoffmann(4), Hidde L. Ploegh(3), Wolfgang Schwede(3), Kristof Chwalisż(3), Ernst Bause(2), Rolf Krattenmacher(2), Emily P. Slater(2), E. Schillinger(2), Holger Hess‐Stumpp(2), Arwed Cleve(2), Günter Neef(2), Michael Klotzbücher(2), Ulrich Nielsch(2), Stefan Jaroch(2), Wiebke Afhüppe(2), Anette Sommer(2), Carsten Möller(2), Karsten Parczyk(2), Andrew C.B. Cato(2)